全文获取类型
收费全文 | 4395篇 |
免费 | 360篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 36篇 |
儿科学 | 91篇 |
妇产科学 | 104篇 |
基础医学 | 412篇 |
口腔科学 | 81篇 |
临床医学 | 538篇 |
内科学 | 921篇 |
皮肤病学 | 61篇 |
神经病学 | 508篇 |
特种医学 | 273篇 |
外科学 | 545篇 |
综合类 | 128篇 |
一般理论 | 6篇 |
预防医学 | 437篇 |
眼科学 | 42篇 |
药学 | 312篇 |
中国医学 | 2篇 |
肿瘤学 | 277篇 |
出版年
2021年 | 81篇 |
2020年 | 49篇 |
2019年 | 70篇 |
2018年 | 83篇 |
2017年 | 59篇 |
2016年 | 76篇 |
2015年 | 69篇 |
2014年 | 104篇 |
2013年 | 168篇 |
2012年 | 194篇 |
2011年 | 218篇 |
2010年 | 158篇 |
2009年 | 125篇 |
2008年 | 205篇 |
2007年 | 225篇 |
2006年 | 179篇 |
2005年 | 167篇 |
2004年 | 165篇 |
2003年 | 186篇 |
2002年 | 125篇 |
2001年 | 113篇 |
2000年 | 129篇 |
1999年 | 120篇 |
1998年 | 49篇 |
1997年 | 63篇 |
1996年 | 55篇 |
1995年 | 45篇 |
1994年 | 43篇 |
1993年 | 38篇 |
1992年 | 84篇 |
1991年 | 80篇 |
1990年 | 64篇 |
1989年 | 88篇 |
1988年 | 72篇 |
1987年 | 67篇 |
1986年 | 66篇 |
1985年 | 85篇 |
1984年 | 77篇 |
1983年 | 62篇 |
1982年 | 50篇 |
1981年 | 33篇 |
1980年 | 38篇 |
1979年 | 59篇 |
1978年 | 53篇 |
1977年 | 57篇 |
1976年 | 46篇 |
1975年 | 37篇 |
1974年 | 36篇 |
1973年 | 37篇 |
1968年 | 28篇 |
排序方式: 共有4774条查询结果,搜索用时 15 毫秒
1.
2.
3.
PADGEM (GMP140) is a component of Weibel-Palade bodies of human endothelial cells 总被引:65,自引:10,他引:55
PADGEM protein (PADGEM), also known as GMP140, is a platelet alpha- granule membrane protein that is translocated to the external membrane after platelet activation. Although the biosynthesis of this protein was originally thought to be confined to megakaryocytes, the synthesis of PADGEM in endothelial cells was recently demonstrated (McEver et al: Blood 70:1974a, 1987). We now describe the subcellular localization of this protein in endothelial cells. Immunofluorescence staining of permeabilized human umbilical vein endothelial cells with KC4, a well characterized monoclonal antibody to PADGEM, showed positively stained elongated structures similar in distribution and shape to Weibel-Palade bodies. Their identity as Weibel-Palade bodies was confirmed by double label immunofluorescence using KC4 and a polyclonal antiserum to von Willebrand factor (vWf), a protein known to be specifically stored in these organelles. All Weibel-Palade bodies were found to contain PADGEM. In contrast to strong perinuclear staining produced with anti- vWf antibodies, no significant perinuclear staining was obtained with KC4, indicating that relatively little PADGEM is present in the endoplasmic reticulum and in the Golgi apparatus. In endothelial cells treated with secretagogues that stimulate vWf release the elongated structures positive for PADGEM disappeared, further identifying these structures as Weibel-Palade bodies. This observation extends the parallels between Weibel-Palade bodies and alpha-granules and suggests a possible functional association between vWf and PADGEM. 相似文献
4.
S Shuman E M Kane S G Morham 《Proceedings of the National Academy of Sciences of the United States of America》1989,86(24):9793-9797
Site-directed mutagenesis of the vaccinia virus gene encoding a type I DNA topoisomerase implicates Tyr-274 as the active-site residue that forms a covalent adduct with DNA during cycles of DNA-strand breakage and reunion. Replacement of Tyr-274 by phenylalanine results in loss of the ability of the enzyme to relax negatively supercoiled DNA as well as to form the covalent DNA-protein intermediate. Substitution of phenylalanine for tyrosine at nine other sites in the protein has no apparent effect on enzyme activity. Amino acid sequence alignment reveals Tyr-274 to be homologous to Tyr-727 and Tyr-771, respectively, of the type I topoisomerases from Saccharomyces cerevisiae and Saccharomyces pombe; Tyr-727 and Tyr-771 have been shown to represent the active-site tyrosines of those enzymes. Sequence comparison of the active-site regions defines a motif Ser-Lys-Xaa-Xaa-Tyr common to the viral and cellular type I topoisomerases, including the human enzyme. 相似文献
5.
D S Rao R Antonelli K R Kane J E Kuhn C Hetnal 《Henry Ford Hospital medical journal》1991,39(1):41-44
Coexistent primary hyperparathyroidism and monoclonal gammopathy, although rare, has been reported previously by a number of investigators. We report four patients with such an occurrence who were seen between 1976 and 1988. Another patient with primary hyperparathyroidism also had multiple myeloma and was in remission for 12 years. These patients represent approximately 1% of the 386 patients with primary hyperparathyroidism seen during the same 12-year period. Although several mechanisms have been proposed to explain this concurrence, we believe it is the result of a chance occurrence. A review of the literature, an estimate of the chance occurrence of coincidental monoclonal gammopathy, benign or malignant, in patients with primary hyperparathyroidism, and some practical implications of this interesting coexistence are presented. 相似文献
6.
7.
Occurrence of the t(2;5)(p23;q35) in non-Hodgkin's lymphoma 总被引:9,自引:3,他引:6
Weisenburger DD; Gordon BG; Vose JM; Bast MA; Chan WC; Greiner TC; Anderson JR; Sanger WG 《Blood》1996,87(9):3860-3868
Primary CD30(Ki-1)-positive anaplastic large-cell lymphoma (ALCL) is considered by some to be a distinct clinicopathologic entity associated with the t(2;5) (p23;q35). However, the specificity of t(2;5) for ALCL has not been carefully studied. Therefore, we performed a detailed analysis of all cases of ALCL with abnormal cytogenetics results in the Nebraska Lymphoma Study Group registry, as well as all other cases of non-Hodgkin's lymphoma with t(2;5) in the registry. We found the t(2;5) in only five of 10 cases of ALCL, four of whom were young patients. However, we also found the t(2;5) in 11 other cases of nonanaplastic lymphoma, including eight children with typical peripheral T-cell lymphomas of various types. The t(2;5) was also found in three older adults with B-cell lymphomas of various types. Thus, the t(2;5) was not specific for CD30+ ALCL. However, t(2;5) may define a clinicopathologic entity in children and young adults characterized by variable morphologies with a T-cell or indeterminate phenotype, CD30-positivity, nodal disease with frequent extranodal involvement, advanced stage, and an excellent response to therapy, including bone marrow transplantation for relapsed disease. The clinical relevance of the t(2;5) in older patients requires further study. 相似文献
8.
9.
10.